Annual legal medical and recreational sales are estimated to grow at a compound annual growth rate (CAGR) of 21%, hitting more than $41 billion by 2025, compared to $13.2 billion in 2019;
That's according to recent data compiled by cannabis-oriented analytics company, New Frontier Data. The firm revealed the findings in its latest update to the U.S. Cannabis Report: 2020-2021 Industry Outlook.
The revision tackles scaled market estimations directly after the passing of six cannabis ballot initiatives, plus a study of cannabis consumer habits influenced by the COVID-19 pandemic.
Among some of the …